GO:0006206 pyrimidine nucleobase metabolic process: Nucleotide Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006206 pyrimidine nucleobase metabolic process describes all chemical reactions and pathways involving pyrimidine nucleobases such as uracil, thymine, and cytosine.
• Pyrimidine nucleobase metabolism is essential for nucleotide synthesis, RNA and DNA building blocks, and cellular energy homeostasis.
• Nucleobase transporters mediate the uptake and salvage of pyrimidine nucleobases, linking extracellular availability to intracellular metabolism.
• Dysregulation of pyrimidine nucleobase metabolism is implicated in cancer, mitochondrial disorders, and developmental defects.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal interrogation of genes in this pathway.
• High-throughput CRISPR library screening combined with metabolomics and RNA-seq can identify novel regulators of pyrimidine nucleobase metabolism.
Description
Pyrimidine nucleobase metabolic process (GO:0006206) encompasses the chemical reactions and pathways involving pyrimidine nucleobases, which are 1,3-diazine organic nitrogenous bases. These bases, including uracil, thymine, and cytosine, are fundamental components of nucleotides and nucleic acids, and their metabolism is tightly linked to RNA and DNA synthesis, cofactor production, and cellular energy balance. The term is a biological process ontology node that groups enzymatic and transport steps that interconvert, salvage, or degrade pyrimidine bases. Understanding this process is critical because pyrimidine nucleobase metabolism intersects with translation, epitranscriptomic regulation, and mitochondrial function. For researchers, GO:0006206 provides a framework to annotate genes and interpret omics data related to nucleotide homeostasis. This article synthesizes authoritative QuickGO definitions and verified PubMed literature to outline the mechanisms, key genes, disease links, and experimental models for studying pyrimidine nucleobase metabolic process.
pyrimidine nucleobase metabolic process At A Glance
| GO ID | GO:0006206 |
|---|---|
| GO term | pyrimidine nucleobase metabolic process |
| Ontology | biological_process |
| Synonym | pyrimidine base metabolic process; pyrimidine base metabolism; pyrimidine metabolic process; pyrimidine metabolism |
| Definition | The chemical reactions and pathways involving pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases. |
| Major function | Synthesis, salvage, interconversion, and transport of pyrimidine nucleobases for nucleotide and nucleic acid biosynthesis. |
| Related processes | Nucleotide salvage, RNA modification, mitochondrial metabolism, and prebiotic RNA formation. |
What Is GO:0006206?
GO:0006206 pyrimidine nucleobase metabolic process is defined as the chemical reactions and pathways involving pyrimidine nucleobases, 1,3-diazine, organic nitrogenous bases. It includes the synthesis, salvage, interconversion, and degradation of uracil, thymine, cytosine, and related analogs, as well as their transport across membranes. This process is distinct from pyrimidine nucleotide metabolic process because it focuses on the free nucleobase level rather than nucleotides.
Why Is pyrimidine nucleobase metabolic process Important in Cell Biology?
Pyrimidine nucleobase metabolic process is central to cellular life because it supplies the building blocks for RNA and DNA and supports cofactors such as NAD and coenzyme Q. Defects in this pathway can impair translation, mitochondrial function, and cell proliferation, contributing to cancer, metabolic disorders, and developmental diseases. Moreover, nucleobase metabolism is a target for chemotherapeutic and antimicrobial strategies, and its evolutionary origins inform prebiotic chemistry.
• Provides precursors for DNA and RNA synthesis, essential for cell division and gene expression.
• Supports epitranscriptomic modifications such as N4-acetylcytidine that regulate translation initiation.
• Links to mitochondrial function via coenzyme Q and NUDT5-mediated nucleotide synthesis.
• Nucleobase transporters control salvage and drug uptake, impacting chemotherapy efficacy.
• Dysregulation is associated with cancer, mitochondrial disorders, and developmental defects.
• Enables prebiotic chemistry studies on the origin of RNA.
• Serves as a target for antimicrobial and anticancer drug development.
• CRISPR screening can uncover novel regulators of pyrimidine nucleobase metabolism.
What Happens During pyrimidine nucleobase metabolic process?
De novo synthesis of pyrimidine nucleobases
In simple terms: The cell builds pyrimidine rings from simple molecules.
De novo pyrimidine biosynthesis generates the pyrimidine ring, which is then converted into nucleobases such as uracil and cytosine. This pathway is essential for providing nucleotides when salvage is insufficient, and it is regulated by demand for nucleic acid synthesis. Nonenzymatic analogs of this pathway have been proposed to explain prebiotic pyrimidine formation.
Salvage and interconversion of nucleobases
In simple terms: The cell recycles free bases into nucleotides.
Salvage pathways convert free pyrimidine nucleobases into nucleotides, conserving energy and maintaining nucleotide pools. Nucleobase transporters facilitate the uptake of extracellular bases, which are then phosphoribosylated by enzymes such as uracil phosphoribosyltransferase. Interconversion between uracil, thymine, and cytosine derivatives ensures balanced nucleotide pools for RNA and DNA synthesis.
Transport of pyrimidine nucleobases
In simple terms: Bases are moved across membranes by dedicated transporters.
Nucleobase transporters are integral membrane proteins that mediate the uptake of pyrimidine bases into cells, a step critical for salvage and drug sensitivity. These transporters are found in organisms ranging from bacteria to humans and are often regulated in response to nucleotide availability. Their activity influences the efficacy of nucleobase analog drugs used in cancer and antiviral therapy.
Degradation and catabolism of pyrimidine nucleobases
In simple terms: Excess bases are broken down for disposal or reuse.
Catabolic pathways degrade pyrimidine nucleobases to intermediates that enter central metabolism, preventing toxic accumulation. Defects in degradation can lead to metabolic disorders, and the balance between synthesis, salvage, and catabolism is crucial for cellular homeostasis. The interplay with mitochondrial metabolism, including coenzyme Q synthesis, highlights the integration of pyrimidine nucleobase metabolism with energy production.
Regulation by nucleotide demand and signaling
In simple terms: The pathway is turned up or down based on what the cell needs.
Pyrimidine nucleobase metabolism is regulated by nucleotide demand, which is sensed through pathways involving mTOR and the integrated stress response. Uridine-sensitized screening has identified NUDT5 and demethoxy-coenzyme Q as regulators of nucleotide synthesis, linking pyrimidine metabolism to mitochondrial function. Epitranscriptomic modifications such as N4-acetylcytidine can also influence translation of metabolic enzymes, adding another layer of regulation.
Key Genes Involved in GO:0006206 pyrimidine nucleobase metabolic process
The following genes and proteins are experimentally implicated in pyrimidine nucleobase metabolic process, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NUDT5 | Regulates nucleotide synthesis and pyrimidine metabolism | Identified in uridine-sensitized screens; links to mitochondrial function |
| UMPS | Catalyzes de novo pyrimidine biosynthesis | Target for cancer and metabolic studies |
| CAD | Multifunctional enzyme in de novo pyrimidine synthesis | Regulated by mTOR and nutrient status |
| DPYD | Degrades pyrimidine bases (dihydropyrimidine dehydrogenase) | Pharmacogenomic marker for 5-fluorouracil toxicity |
| UPP1 | Salvage of uracil to UMP | Involved in nucleotide homeostasis |
| UCK2 | Phosphorylates uridine and cytidine | Links nucleobase salvage to nucleotide pools |
| SLC29A1 | Nucleoside transporter | Mediates uptake of nucleobase analogs |
| SLC29A2 | Nucleoside transporter | Affects drug sensitivity |
| SLC23A2 | Nucleobase transporter | Regulates intracellular pyrimidine levels |
| NAT10 | RNA acetyltransferase for N4-acetylcytidine | Links pyrimidine metabolism to translation |
| NME1 | Nucleoside diphosphate kinase | Supports nucleotide homeostasis |
| NME2 | Nucleoside diphosphate kinase | Supports nucleotide homeostasis |
| TYMS | Thymidylate synthase | Target of 5-fluorouracil; pyrimidine metabolism |
| DHFR | Dihydrofolate reductase | Interconnects folate and pyrimidine metabolism |
| GART | Purine biosynthesis, but cross-talk with pyrimidines | Metabolic network studies |
| PPAT | Phosphoribosyl pyrophosphate amidotransferase | Purine synthesis, cross-talk |
| NUDT1 | Nudix hydrolase | Sanitizes oxidized nucleotides |
| NUDT15 | Nudix hydrolase | Thiopurine metabolism and pyrimidine cross-talk |
How Is pyrimidine nucleobase metabolic process Regulated?
Pyrimidine nucleobase metabolic process is regulated at multiple levels. Nutrient-sensing pathways such as mTOR control the expression of de novo synthesis enzymes like CAD in response to nucleotide demand. The integrated stress response can modulate translation of metabolic enzymes, and epitranscriptomic marks such as N4-acetylcytidine on RNA can influence translation initiation of genes involved in nucleotide synthesis. Additionally, feedback inhibition by downstream nucleotides and regulation of nucleobase transporters control flux through salvage pathways. Uridine-sensitized screening has revealed that NUDT5 and demethoxy-coenzyme Q regulate nucleotide synthesis, linking pyrimidine metabolism to mitochondrial function.
pyrimidine nucleobase metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NUDT5 | Mitochondrial dysfunction, nucleotide synthesis defects | Knockout in HeLa or HEK293 cells followed by metabolomics |
| DPYD | 5-fluorouracil toxicity, pyrimidine degradation deficiency | Point mutation knock-in in iPSC-derived hepatocytes |
| UMPS | Orotic aciduria, cancer proliferation | Knockout in cancer cell lines |
| NAT10 | Translation defects, neurodevelopmental disorders | Knock-in of acetyltransferase-dead mutant |
| SLC29A1 | Drug resistance, nucleoside transport defects | Overexpression in cancer cells |
Cancer and chemoresistance
Altered pyrimidine nucleobase metabolism supports rapid proliferation of cancer cells and contributes to resistance to antimetabolite drugs such as 5-fluorouracil. High expression of de novo synthesis enzymes and salvage transporters can sustain nucleotide pools under stress, making this pathway a target for therapeutic intervention.
Mitochondrial disorders and metabolic disease
Defects in pyrimidine nucleobase metabolism, including impaired coenzyme Q synthesis and NUDT5 function, are associated with mitochondrial dysfunction and metabolic disorders. Uridine-sensitized screening has linked pyrimidine metabolism to mitochondrial respiration, suggesting that nucleobase availability affects energy production.
Neurodevelopmental and translation-related disorders
Epitranscriptomic regulation by N4-acetylcytidine, which depends on pyrimidine metabolism, can affect translation initiation and neuronal development. Disruption of RNA-modifying enzymes that use pyrimidine-derived cofactors has been implicated in neurodevelopmental disorders.
From pyrimidine nucleobase metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is NUDT5 required for pyrimidine nucleobase metabolism? | CRISPR knockout in HEK293T cells |
| Does a point mutation in DPYD alter 5-FU sensitivity? | Point mutation knock-in in HCT116 cells |
| Can overexpression of UMPS rescue nucleotide depletion? | Overexpression in cancer cell lines |
| How does N4-acetylcytidine affect translation of metabolic genes? | Tagged knock-in of NAT10 in HeLa cells |
| What transporters mediate uracil uptake? | Knockout of SLC29A1/2 in epithelial cells |
| Can CRISPR screening identify new regulators of pyrimidine metabolism? | Genome-wide CRISPR library in uridine-sensitized cells |
How to Study the pyrimidine nucleobase metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of pyrimidine nucleobases and nucleotides | Pathway activity in knockout cells |
| Ribo-seq | Translation efficiency of metabolic enzymes | Epitranscriptomic regulation |
| RNA-seq | Gene expression changes | CRISPR knockout validation |
| CRISPR library screening | Fitness genes under uridine sensitization | Discovery of novel regulators |
| Transport assays | Uptake kinetics of nucleobases | Characterization of SLC transporters |
| Western blot | Protein expression of metabolic enzymes | Validation of overexpression or knockout |
| Immunofluorescence | Subcellular localization of enzymes | Mitochondrial vs cytosolic localization |
| Prebiotic chemistry assays | Nonenzymatic pyrimidine synthesis | Origin of life studies |
Metabolomics and flux analysis
Mass spectrometry-based metabolomics quantifies pyrimidine nucleobases and nucleotides, revealing pathway activity and flux. Isotope tracing can determine de novo synthesis versus salvage contributions.
RNA-seq and Ribo-seq
RNA-seq measures expression of metabolic genes, while Ribo-seq assesses translation efficiency of enzymes involved in pyrimidine nucleobase metabolism. These methods can uncover epitranscriptomic regulation by N4-acetylcytidine.
CRISPR screening
Genome-wide CRISPR knockout or activation screens under uridine sensitization can identify genes that regulate pyrimidine nucleobase metabolism and mitochondrial function. Hits such as NUDT5 validate the approach.
Transport assays
Radiolabeled or fluorescent nucleobase uptake assays in cells expressing wild-type or mutant transporters measure transport kinetics and inhibitor sensitivity. These assays are useful for studying SLC29A and SLC23A family members.
How CRISPR Can Be Used to Study GO:0006206 pyrimidine nucleobase metabolic process
Knockout
CRISPR knockout of genes such as NUDT5 or UMPS in cell lines can reveal their requirement for pyrimidine nucleobase metabolism and cell proliferation. Knockout models are validated by metabolomics and rescue experiments.
Point Mutation
Point mutation knock-in of catalytic residues or patient variants in DPYD or UMPS allows precise testing of enzyme function and drug sensitivity. These models are useful for pharmacogenomics.
Knock-in
Tagged knock-in of NAT10 or metabolic enzymes enables localization and interaction studies without overexpression artifacts. Knock-in of reporter cassettes can track pathway activity in live cells.
Overexpression
Overexpression of salvage enzymes or transporters can model chemoresistance and identify rate-limiting steps in pyrimidine nucleobase metabolism. Overexpression models are also used to study prebiotic pathway analogs.
How EDITGENE Supports pyrimidine nucleobase metabolic process Research
Researchers studying pyrimidine nucleobase metabolic process-related genes often need to determine whether a candidate gene is causally involved in nucleotide homeostasis, drug response, or mitochondrial function. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models that answer these questions.
Contact EDITGENE today to design your custom CRISPR model for pyrimidine nucleobase metabolic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TYMP Knockout HEK293 Cell Line | EDJ-KQ2212 | Human | 1890 | Details Get a Quote |
| TYMP Knockout A-549 Cell Line | EDJ-KQ22468 | Human | 1890 | Details Get a Quote |
| TYMP Knockout HCT 116 Cell Line | EDJ-KQ22469 | Human | 1890 | Details Get a Quote |
| TYMP Knockout HeLa Cell Line | EDJ-KQ22470 | Human | 1890 | Details Get a Quote |
Displaying Records 1 To 4 Of 4 Records
Frequently Asked Questions About pyrimidine nucleobase metabolic process
What is pyrimidine nucleobase metabolic process?
It is the set of chemical reactions and pathways involving pyrimidine nucleobases such as uracil, thymine, and cytosine, as defined by GO:0006206.
What genes are involved in pyrimidine nucleobase metabolic process?
Key genes include NUDT5, UMPS, CAD, DPYD, UPP1, UCK2, and nucleobase transporters such as SLC29A1 and SLC23A2.
Why is pyrimidine nucleobase metabolism important for cancer?
Cancer cells rely on pyrimidine metabolism for rapid proliferation and drug resistance, making it a therapeutic target.
How is pyrimidine nucleobase metabolism regulated?
It is regulated by nucleotide demand, mTOR signaling, and epitranscriptomic modifications such as N4-acetylcytidine.
What diseases are linked to pyrimidine nucleobase metabolic process?
Cancer, mitochondrial disorders, and neurodevelopmental conditions have been associated with defects in this pathway.
What methods study pyrimidine nucleobase metabolism?
Metabolomics, RNA-seq, Ribo-seq, CRISPR screening, and transport assays are commonly used.
Can CRISPR knockout help study pyrimidine nucleobase metabolism?
Yes, CRISPR knockout of genes like NUDT5 or UMPS can reveal their function in nucleotide synthesis.
What is the role of nucleobase transporters in pyrimidine metabolism?
They mediate uptake of pyrimidine bases and analogs, affecting salvage and drug sensitivity.
How does N4-acetylcytidine relate to pyrimidine metabolism?
N4-acetylcytidine is an RNA modification that can regulate translation of metabolic genes, linking pyrimidine metabolism to translation.
What are prebiotic implications of pyrimidine nucleobase synthesis?
Nonenzymatic pathways may explain how pyrimidines formed on early Earth, informing origin-of-life research.
Conclusion
Pyrimidine nucleobase metabolic process (GO:0006206) is a fundamental biological process that supplies the building blocks for nucleic acids and supports mitochondrial and translational functions. Its dysregulation is linked to cancer, metabolic disorders, and developmental defects, making it a rich area for research. By combining CRISPR models with metabolomics and sequencing, researchers can dissect the causal roles of individual genes and identify new therapeutic targets. EDITGENE offers comprehensive CRISPR services to accelerate these discoveries.
References
- 1. Arango D et al.. 2022. Direct epitranscriptomic regulation of mammalian translation initiation through N4-acetylcytidine.. Mol Cell 82(15):2797-2814.e11 PMID: 35679869
- 2. de Koning H et al.. 2000. Nucleobase transporters (review).. Mol Membr Biol 17(2):75-94 PMID: 10989458
- 3. Yi J et al.. 2022. A Nonenzymatic Analog of Pyrimidine Nucleobase Biosynthesis.. Angew Chem Int Ed Engl 61(23):e202117211 PMID: 35304939
- 4. Strefeler A et al.. 2025. Uridine-sensitized screening identifies demethoxy-coenzyme Q and NUDT5 as regulators of nucleotide synthesis.. Nat Metab 7(11):2221-2235 PMID: 41233602
- 5. Ferré-D'Amaré AR. 2003. RNA-modifying enzymes.. Curr Opin Struct Biol 13(1):49-55 PMID: 12581659
- 8. Banfalvi G. 2021. Prebiotic Pathway from Ribose to RNA Formation.. Int J Mol Sci 22(8) PMID: 33917807
